Literature DB >> 28096063

Chest trauma: First 48hours management.

Pierre Bouzat1, Mathieu Raux2, Jean Stéphane David3, Karim Tazarourte4, Michel Galinski5, Thibault Desmettre6, Delphine Garrigue7, Laurent Ducros8, Pierre Michelet9, Marc Freysz10, Dominique Savary10, Fatima Rayeh-Pelardy10, Christian Laplace10, Raphaelle Duponq10, Valérie Monnin Bares10, Xavier Benoît D'Journo10, Guillaume Boddaert10, Mathieu Boutonnet10, Sébastien Pierre10, Marc Léone10, Didier Honnart10, Mathieu Biais10, Fanny Vardon10.   

Abstract

Chest trauma remains an issue for health services for both severe and apparently mild trauma management. Severe chest trauma is associated with high mortality and is considered liable for 25% of mortality in multiple traumas. Moreover, mild trauma is also associated with significant morbidity especially in patients with preexisting conditions. Thus, whatever the severity, a fast-acting strategy must be organized. At this time, there are no guidelines available from scientific societies. These expert recommendations aim to establish guidelines for chest trauma management in both prehospital an in hospital settings, for the first 48hours. The "Société française d'anesthésie réanimation" and the "Société française de médecine d'urgence" worked together on the 7 following questions: (1) criteria defining severity and for appropriate hospital referral; (2) diagnosis strategy in both pre- and in-hospital settings; (3) indications and guidelines for ventilatory support; (4) management of analgesia; (5) indications and guidelines for chest tube placement; (6) surgical and endovascular repair indications in blunt chest trauma; (7) definition, medical and surgical specificity of penetrating chest trauma. For each question, prespecified "crucial" (and sometimes also "important") outcomes were identified by the panel of experts because it mattered for patients. We rated evidence across studies for these specific clinical outcomes. After a systematic Grade® approach, we defined 60 recommendations. Each recommendation has been evaluated by all the experts according to the DELPHI method.
Copyright © 2017 Société française d'anesthésie et de réanimation (Sfar). Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Analgesia; Blunt Chest Trauma; Chest Trauma; Intensive Care; Penetrating Chest Trauma; Severity Criteria; Ventilation

Mesh:

Year:  2017        PMID: 28096063     DOI: 10.1016/j.accpm.2017.01.003

Source DB:  PubMed          Journal:  Anaesth Crit Care Pain Med        ISSN: 2352-5568            Impact factor:   4.132


  5 in total

Review 1.  [Blunt and penetrating thoracic trauma].

Authors:  B Mühling
Journal:  Chirurg       Date:  2017-09       Impact factor: 0.955

2.  Emergency department thoracotomy in a physician-staffed trauma system: the experience of a French Military level-1 trauma center.

Authors:  Hilaire de Malleray; Michael Cardinale; Jean-Philippe Avaro; Eric Meaudre; Tristan Monchal; Stéphane Bourgouin; Mathieu Vasse; Paul Balandraud; Henri de Lesquen
Journal:  Eur J Trauma Emerg Surg       Date:  2022-05-28       Impact factor: 3.693

3.  Risk Factors Associated with Mortality in Severe Chest Trauma Patients Admitted to the ICU.

Authors:  Jesús Abelardo Barea-Mendoza; Mario Chico-Fernández; Manuel Quintana-Díaz; Jon Pérez-Bárcena; Luís Serviá-Goixart; Ismael Molina-Díaz; María Bringas-Bollada; Antonio Luis Ruiz-Aguilar; María Ángeles Ballesteros-Sanz; Juan Antonio Llompart-Pou
Journal:  J Clin Med       Date:  2022-01-05       Impact factor: 4.241

4.  Traumatic brain injury in children with thoracic injury: clinical significance and impact on ventilatory management.

Authors:  Caroline Baud; Benjamin Crulli; Jean-Noël Evain; Clément Isola; Isabelle Wroblewski; Pierre Bouzat; Guillaume Mortamet
Journal:  Pediatr Surg Int       Date:  2021-07-07       Impact factor: 1.827

Review 5.  EPIDURAL ANALGESIA IN MULTIPY INJURED PATIENTS WITH SEVERE CHEST TRAUMA: TWO CASE REPORTS AND LITERATURE REVIEW.

Authors:  Nina Sulen; Tatjana Šimurina; Edi Karuc; Anela Tolić
Journal:  Acta Clin Croat       Date:  2019-06       Impact factor: 0.780

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.